22 May: Prof. Aaron Ciechanover, Scientific Advisory Board

Prof. Ciechanover received the Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation. In this discovery, he provided a key to understanding the ubiquitin system and paved the way for the development of drugs to prevent and treat certain illnesses. He has made a great contribution to the understanding of the mechanism of intracellular processes. Prof. Ciechanover has accompanied Carmel Diagnostics (and its predecessor, Lumitest) since 2003, and advises the company on strategic subjects, helping management to set development directions, to determine and focus on specific applications, and to position the company in the scientific world.

abraham reznick

22 May: Prof. Abraham Z. Reznick,Senior Consultant

Prof. Reznick is a global expert in oxidative stress research and the President of the Israeli Society for Oxygen and Free Radicals Research. Prof. Reznick’s research group is involved in oxidative stress with special regard to muscle immobilization and aging, as well as cigarette- and smoke-related damage. His main research projects include the use of ThermoChemiLuminescence (TCL) to detect biological oxidation. Prof. Reznick is a Lecturer at the University of Haifa, Department of Gerontology, as well as an Associate Professor at the Technion Israel Institute of Technology. He received his PhD in Biochemistry from Florida State University.

martha dirnfeld

22 May: Prof. Martha Dirnfeld

Prof. Dirnfeld has been the president of the Israeli Fertility Society (IFS). She is Head of the Division of Reproductive Endocrinology and IDF at the Carmel Medical Center and a member of the Faculty of Medicine at the Technion Israel Institute of Technology. Prof. Dirnfeld is the National Committee Representative to the ESHRE in Europe. She graduated with an MD from the Technion Israel Institute of Technology. Prof. Dirnfeld was Board Certified in obstetrics and gynaecology following her residency at the Free University of Brussels and Carmel Medical Centre. She serves as Carmel’s fertility expert and advisor on clinical issues regarding women’s health.


22 May: Zofnat Wiener-Magnazi,MD

Dr. Zofnat Wiener-Megnazi is an expert physician in obstetrics, gynecology, and fertility with vast experience in IVF treatment. She is Manager of the sperm bank in the unit and a leading force in our research activity. Dr. Wiener-Megnazi was principal investigator of our “proof of concept” study in embryo selection application and is responsible for four articles on the fertility application of oxidative stress as a biomarker. She graduated in Medicine at the Hebrew University, Jerusalem, Israel. Dr. Wiener-Megnazi is teaching in the medical school of the Technion and guides students in their research.